Hydration Pharmaceuticals Co. Ltd. (AU:HPC) has released an update.
Hydration Pharmaceuticals Co. Ltd. has successfully divested its non-US Hydralyte assets to Prestige Consumer Healthcare Inc. for approximately $9.5 million, a move that allows the repayment of an $8.2 million debt and funds the expansion of its US operations. The company’s US business, retaining full ownership, is focusing on e-commerce growth and operational streamlining, targeting profitability in the lucrative US market after showing promising net margin growth and success on Amazon USA.
For further insights into AU:HPC stock, check out TipRanks’ Stock Analysis page.